NICE has recommended dupilumab, a first-of-its-kind targeted COPD treatment that reduces flare-ups and improves lung function ...

Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...

Dec. 10—(StatePoint) More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD.

Temple Health is testing a tiny, flexible scaffold aimed at relieving a common problem for emphysema patients: overinflation ...

Are you finding that your chronic obstructive pulmonary disease (COPD) is making it harder to do the things you enjoy? Canceling plans more often? Missing work due to flare-ups? It could mean your ...

BARCELONA -- Eligible emphysema patients had similar levels of improvement whether treated with lung volume reduction surgery (LVRS) or bronchoscopic lung volume reduction (BLVR) with valve placement, ...

The hospital said it's the first in Northwest Indiana to offer the Zephyr Valve system, a minimally invasive procedure approved by the Food and Drug Administration. It requires no incisions and aims ...

Chronic obstructive pulmonary disease (COPD) is a group of diseases, including chronic bronchitis and emphysema, that block your airways and make it hard for you to breathe. Today, doctors understand ...